Sorafenib in First-line Treatment of Advanced B Child Hepatocellular Carcinoma
Clinical trial NCT01405573 · TERMINATED
Trial details
- NCT number
- NCT01405573
- Sponsor
- National Cancer Institute, Naples
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2017-03-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.